A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones
Mary Ellen Taplin, Judith Manola, William K. Oh, Philip W. Kantoff, Glenn J. Bubley, Matthew Smith, Diana Barb, Christos Mantzoros, Edward P. Gelmann, Steven P. Balk
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones'. Together they form a unique fingerprint.